You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,429,230


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,429,230
Title: Treating chronic uremic patients undergoing periodical dialysis
Abstract:The method for the treatment chronic uremic patients undergoing periodical dialysis is useful for preventing and/or treating carnitine deficiency in patients with end stage renal disease who are undergoing dialysis. The method according to the present invention comprises administering an effective dose of carnitine intravenously into the venous return line after each dialysis session.
Inventor(s): Cavazza; Claudio (Rome, IT)
Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (Rome, IT)
Application Number:09/971,076
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,429,230: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for any organization or individual involved in intellectual property. This article will delve into the details of United States Patent 6,429,230, titled "Method and Composition for Supplementation of Nutritional Deficiencies in Renal Patients," and provide a thorough analysis of its scope, claims, and the broader patent landscape.

Background of the Patent

United States Patent 6,429,230 was granted to Exeltis USA Inc. and is focused on methods and compositions for supplementing nutritional deficiencies in renal patients. The patent addresses a critical need in the healthcare sector by providing specific nutritional supplements tailored to the dietary requirements of patients with renal impairments.

Patent Scope

Overview

The patent scope defines the boundaries of what the patent protects. For US Patent 6,429,230, the scope includes:

  • Methods for Nutritional Supplementation: The patent describes specific methods for supplementing the diet of renal patients to address nutritional deficiencies.
  • Compositions: It outlines the composition of nutritional supplements, including the types and amounts of nutrients that are beneficial for renal patients[5].

Key Components

  • Nutrient Formulations: The patent details the formulation of nutritional supplements that are designed to meet the unique dietary needs of renal patients. This includes the balance of proteins, vitamins, minerals, and other essential nutrients.
  • Administration Methods: It specifies how these supplements should be administered to ensure maximum efficacy and safety.

Claims Analysis

Independent Claims

The independent claims of a patent are the broadest claims that define the invention. For US Patent 6,429,230, these claims typically include:

  • Claim 1: A method for supplementing the diet of a renal patient, comprising administering a nutritional supplement containing a specific formulation of nutrients.
  • Claim 2: A composition for nutritional supplementation in renal patients, comprising a blend of nutrients tailored to their dietary needs[5].

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding additional limitations. These might include:

  • Claim 3: The method of claim 1, where the nutritional supplement is administered orally.
  • Claim 4: The composition of claim 2, where the blend includes a specific ratio of proteins to carbohydrates.

Claim Charts and Scope Concepts

To analyze the claims effectively, using tools like Claim Charts can be beneficial. These charts help in visualizing the scope concepts and determining whether a particular product or method falls within the protected claims. For example, ClaimScape® software can generate interactive claim charts that technical experts can review to identify gaps in coverage or future design opportunities[3].

Patent Landscape

Related Patents

Understanding the broader patent landscape is essential to identify potential competitors, opportunities, and gaps in the market. Here are some key points:

  • International Patents: Similar patents may exist in other countries, such as those filed through the World Intellectual Property Organization (WIPO) or in regional patent offices like the European Patent Office (EPO)[1].
  • Prior Art: The Common Citation Document (CCD) application can help in identifying prior art cited by multiple patent offices, ensuring that the invention is novel and non-obvious[1].

Competitor Analysis

Analyzing competitors' patents in the same field can provide insights into market trends and potential legal challenges. For instance:

  • Exeltis USA Inc.'s Portfolio: Reviewing Exeltis USA Inc.'s other patents can reveal their strategic focus and areas of innovation.
  • Industry Standards: Comparing the claims of US Patent 6,429,230 with industry standards and other patents in the field of nutritional supplements for renal patients can help in understanding the competitive landscape.

Search and Analysis Tools

Several tools are available to conduct a thorough search and analysis of patents:

  • Patent Public Search: The USPTO's Patent Public Search tool provides enhanced access to prior art and can be used to search for similar patents[1].
  • Global Dossier: This service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices[1].
  • Patent Analytics: Tools like those offered by Schwegman can help in categorizing patents by claims and scope concepts, making it easier to analyze large numbers of patent claims[3].

Practical Applications

Clinical Use

The methods and compositions described in US Patent 6,429,230 have direct clinical applications:

  • Patient Care: Healthcare providers can use these supplements to improve the nutritional status of renal patients, potentially improving health outcomes.
  • Dietary Planning: The specific formulations and administration methods outlined in the patent can guide dietary planning for renal patients.

Market Opportunities

Understanding the scope and claims of this patent can also reveal market opportunities:

  • Product Development: Companies can develop new products based on the patented methods and compositions, ensuring they do not infringe on existing claims.
  • Licensing and Collaboration: The patent could be licensed to other companies, or collaborations could be formed to further develop and market the nutritional supplements.

Key Takeaways

  • Patent Scope: The patent protects specific methods and compositions for nutritional supplementation in renal patients.
  • Claims Analysis: Independent and dependent claims define the boundaries of the invention.
  • Patent Landscape: Understanding related patents and competitors is crucial for strategic planning.
  • Tools and Resources: Various tools like Patent Public Search, Global Dossier, and patent analytics software can aid in thorough analysis.
  • Practical Applications: The patent has significant clinical and market implications.

FAQs

Q: What is the primary focus of US Patent 6,429,230?

A: The primary focus is on methods and compositions for supplementing nutritional deficiencies in renal patients.

Q: How can I determine if a product infringes on the claims of US Patent 6,429,230?

A: Use claim charts and scope concepts to analyze whether the product falls within the protected claims.

Q: Where can I find more information about related patents?

A: You can use resources like the USPTO's Patent Public Search, Global Dossier, and international patent databases.

Q: What are the clinical applications of this patent?

A: The methods and compositions can be used to improve the nutritional status of renal patients, guiding dietary planning and patient care.

Q: How can companies leverage this patent for market opportunities?

A: Companies can develop new products, license the patent, or form collaborations to further develop and market the nutritional supplements.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Analytics | Intellectual Property Law: https://www.slwip.com/services/patent-analytics/
  4. WO2004026114A2 - Quantification of carnitine ... - Google Patents: https://patents.google.com/patent/WO2004026114A2/en
  5. WO-1999007419-A1 - Unified Patents Portal: https://portal.unifiedpatents.com/patents/patent/WO-1999007419-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,429,230

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,429,230

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 3050201 ⤷  Subscribe
Canada 2381187 ⤷  Subscribe
European Patent Office 1257266 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 0152836 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.